Shorter Radiation Course Effective for Prostate Cancer
Standard radiation for treating cancer usually lasts a matter of weeks. Researchers are now finding that shortening that time has long-lasting benefits for prostate cancer patients.
Is Ageism Affecting Prostate Cancer Treatment?
There's been a great deal of debate about if and/or how to treat men in their mid-70s who have prostate cancer. A new study shows that doctors are either under- or over-treating the disease in this age group.
Advanced Prostate Cancer Breakthrough?
The treatment options for advanced prostate cancer that's spread to the bone are minimal at this point. An experimental drug that's currently being tested may soon change the outlook for patients.
When Can I Enjoy Sex Again?
Prostate cancer treatment typically interferes with sexual function. It's to be expected. Now, doctors have a way of predicting when normal sexual activity will resume.
Detecting Cancer With Implantable Light
Imagine having a tiny light implanted in your body that could signal when cancer appears. Just such an invention may be just around the corner.
Is Prostate Cancer More Common in Black Men?
Prostate cancer cases and deaths are more common in African-American men than in white men, and scientists have recently identified what's behind this disparity.
Prostate Cancer Trends
September is prostate cancer awareness month, and the latest statistics of new cases have been released by the Centers for Disease Control and Prevention (CDC).
Resistant Prostate Cancer has new Enemy
Some forms of prostate cancer don't respond to any available therapies. An investigational compound currently being studied in clinical trials may soon change that.
Prostate Cancer Screening Upgrade
The cancer men fear most has no clear-cut means of being easily detected. The most common test commonly generates false results. A new test being developed may be more accurate and more reliable.
Pinpointing Lethal DNA
This puzzle is millions of times more complex than the Rubik's cube. Yet scientists are getting a handle on two genes that determine the prognosis for prostate cancer patients.